BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

713 related articles for article (PubMed ID: 27252265)

  • 21. Neuropsychiatric systemic lupus erythematosus: magnetic resonance imaging findings and correlation with clinical and immunological features.
    Toledano P; Sarbu N; Espinosa G; Bargalló N; Cervera R
    Autoimmun Rev; 2013 Oct; 12(12):1166-70. PubMed ID: 23851139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiphospholipid Antibodies are Associated with Low Levels of Complement C3 and C4 in Patients with Systemic Lupus Erythematosus.
    Garabet L; Gilboe IM; Mowinckel MC; Jacobsen AF; Mollnes TE; Sandset PM; Jacobsen EM
    Scand J Immunol; 2016 Aug; 84(2):95-9. PubMed ID: 27135178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors and comorbidities associated with central nervous system involvement in systemic lupus erythematosus: a retrospective cross-sectional case-control study from a single center.
    Padovan M; Castellino G; Bortoluzzi A; Caniatti L; Trotta F; Govoni M
    Rheumatol Int; 2012 Jan; 32(1):129-35. PubMed ID: 20676648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of anti-DNA/N-methyl-D-aspartate receptor 2 antibodies in de novo and post-steroid cases with neuropsychiatric systemic lupus erythematosus.
    Fujieda Y; Mader S; Jeganathan V; Arinuma Y; Shimizu Y; Kato M; Oku K; Minami A; Shimizu C; Yasuda S; Atsumi T
    Int J Rheum Dis; 2019 Mar; 22(3):443-448. PubMed ID: 30358102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum neuron specific enolase - a novel indicator for neuropsychiatric systemic lupus erythematosus?
    Hawro T; Bogucki A; Krupińska-Kun M; Maurer M; Woźniacka A
    Lupus; 2015 Dec; 24(14):1492-7. PubMed ID: 26124236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utility of interferon-α as a biomarker in central neuropsychiatric involvement in systemic lupus erythematosus.
    Fragoso-Loyo H; Atisha-Fregoso Y; Núñez-Alvarez CA; Llorente L; Sánchez-Guerrero J
    J Rheumatol; 2012 Mar; 39(3):504-9. PubMed ID: 22247358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential activation mechanisms of serum C5a in lupus nephritis and neuropsychiatric systemic lupus erythematosus.
    Sakuma Y; Nagai T; Yoshio T; Hirohata S
    Mod Rheumatol; 2017 Mar; 27(2):292-297. PubMed ID: 27319578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of anti-ribosomal P protein antibodies with neuropsychiatric and other manifestations of systemic lupus erythematosus.
    Abdel-Nasser AM; Ghaleb RM; Mahmoud JA; Khairy W; Mahmoud RM
    Clin Rheumatol; 2008 Nov; 27(11):1377-85. PubMed ID: 18481154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intractable headaches, ischemic stroke, and seizures are linked to the presence of anti-β2GPI antibodies in patients with systemic lupus erythematosus.
    Hawro T; Bogucki A; Krupińska-Kun M; Maurer M; Woźniacka A
    PLoS One; 2015; 10(3):e0119911. PubMed ID: 25781014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuropsychiatric manifestations and associated autoantibodies in systemic lupus erythematosus patients from Western India.
    Pradhan V; Patwardhan M; Rajadhyaksha A; Dhawale N; Ghosh K
    Rheumatol Int; 2015 Mar; 35(3):541-5. PubMed ID: 25119833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q.
    Mok CC; Birmingham DJ; Ho LY; Hebert LA; Song H; Rovin BH
    Lupus; 2012 Jan; 21(1):36-42. PubMed ID: 21993384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers.
    Akhter E; Burlingame RW; Seaman AL; Magder L; Petri M
    Lupus; 2011 Oct; 20(12):1267-74. PubMed ID: 21813587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of antibodies to the NR1 subunit of N-methyl-D-aspartate receptors with neuropsychiatric systemic lupus erythematosus.
    Ogawa E; Nagai T; Sakuma Y; Arinuma Y; Hirohata S
    Mod Rheumatol; 2016; 26(3):377-83. PubMed ID: 26429674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A study on anti-mannose binding lectin (anti-MBL) antibodies and serum MBL levels in Indian systemic lupus erythematosus patients.
    Pradhan V; Mahant G; Rajadhyaksha A; Surve P; Rajendran V; Patwardhan M; Nadkarni A; Dighe S; Ghosh K
    Rheumatol Int; 2013 May; 33(5):1193-9. PubMed ID: 22971892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort.
    Mikdashi J; Handwerger B
    Rheumatology (Oxford); 2004 Dec; 43(12):1555-60. PubMed ID: 15342927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brain magnetic resonance imaging, cerebrospinal fluid, and autoantibody profile in 118 patients with neuropsychiatric lupus.
    Tan Z; Zhou Y; Li X; Wang G; Tao J; Wang L; Ma Y; Li X
    Clin Rheumatol; 2018 Jan; 37(1):227-233. PubMed ID: 29103181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunological biomarkers in neuropsychiatric systemic lupus erythematosus: a comparative cross-sectional study from a tertiary care center in South India.
    Seth G; Sundaresh A; Mariaselvam CM; Kumar G; Chengappa KG; Adarsh MB; Tamouza R; Negi VS
    Lupus; 2020 Apr; 29(4):413-420. PubMed ID: 32106787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Familial clustering of non-nuclear autoantibodies and C3 and C4 complement components in systemic lupus erythematosus.
    Hunnangkul S; Nitsch D; Rhodes B; Chadha S; Roberton CA; Pessôa-Lopes P; Norsworthy PJ; Fernando MM; Charles P; Mackworth-Young C; Isenberg DA; Whittaker JC; Vyse TJ
    Arthritis Rheum; 2008 Apr; 58(4):1116-24. PubMed ID: 18383369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of C1q polymorphisms suggests association with systemic lupus erythematosus, serum C1q and CH50 levels and disease severity.
    Martens HA; Zuurman MW; de Lange AH; Nolte IM; van der Steege G; Navis GJ; Kallenberg CG; Seelen MA; Bijl M
    Ann Rheum Dis; 2009 May; 68(5):715-20. PubMed ID: 18504288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.